Biotechnology reagents market set to reach $148.21 billion by 2030

The biotechnology reagents market is forecast to grow from $101.21 billion in 2026 to $148.21 billion by 2030, driven by rising demand for PCR, precision diagnostics, genomics and automated lab systems. North America led the market in 2025, while Asia-Pacific is projected to grow the fastest.

Why it matters: - Biotechnology reagents sit at the center of research, diagnostics and lab workflows. - Faster growth in PCR, genomics, proteomics and precision medicine is expanding demand across healthcare and life sciences. - The market outlook points to wider adoption of automated systems and higher expectations for accuracy and reproducibility.

What happened: - The Business Research Company released its Biotechnology Reagents Global Market Report 2026, covering market size, trends and forecasts through 2035. - The market was valued at $92.14 billion in 2025 and is projected to reach $101.21 billion in 2026. - The report forecasts the market will climb to $148.21 billion by 2030. - The report was published Nov. 6, 2026, from London. - Download a free sample of the biotechnology reagents market report - View the full biotechnology reagents market report

The details: - The market's 2025-to-2026 growth rate is 9.8%. - The forecast from 2026 to 2030 implies a 10.0% CAGR. - Growth is being driven by expanded biotechnology research, higher pharmaceutical R&D spending, broader use of molecular diagnostics and stronger academic funding. - Additional support is coming from improved laboratory infrastructure. - Looking ahead, demand is expected to rise from precision diagnostics, genomics and proteomics research, personalized medicine funding, automated laboratory systems and the need for reproducible results. - Emerging trends include high-purity molecular biology reagents, more sophisticated analytical reagents, wider use of PCR and gene expression kits, and more automated workflows. - Biotechnology reagents are specialized chemical compounds used to detect, measure and prepare products through chemical reactions. - These reagents help identify target substances by triggering specific biochemical responses. - PCR demand is a major growth driver because PCR amplifies small DNA segments for infectious disease diagnosis and genetic analysis. - Biotechnology reagents help maintain stable PCR conditions, including pH balance, for accurate DNA synthesis. - The World Health Organization reported in March 2025 that weekly SARS-CoV-2 PCR test positivity rates fell from 7.3% to 5.0% during Jan. 6-Feb. 2, 2025, with more than 69,900 samples tested weekly across 103 countries. - North America held the largest market share in 2025. - Asia-Pacific is expected to be the fastest-growing region over the forecast period. - The report also covers South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa.

Between the lines: - The report's emphasis on automation and consistency suggests the market is shifting from basic reagent demand toward higher-value, performance-sensitive products. - Persistent PCR usage signals that diagnostic testing remains a core demand engine, even as applications broaden into genomics and personalized medicine. - Regional growth patterns suggest mature markets will keep scale, while faster expansion is likely to come from Asia-Pacific.

What's next: - The market is expected to keep expanding through 2030 as precision diagnostics and life sciences research deepen. - Reagent makers will likely compete on purity, consistency, automation compatibility and workflow efficiency. - The report's broader 2035 forecast horizon points to continued long-term investment interest in the category.

The bottom line: - Biotechnology reagents are moving from steady lab inputs to a high-growth market tied to diagnostics, genomics and automated research workflows.